Resumen
Optimizing prophylaxis against venous thromboembolic events (VTEs) is a critical issue in the care of injured patients. Although these patients are at significant risk of developing VTE, they also present competing concerns related to exacerbation of bleeding from existing injuries. Especially after high-risk trauma, including injuries to the abdominal solid organs, brain, and spine, trauma providers must delineate the time period in which VTE prophylaxis successfully reduces VTE rates without encouraging bleeding. Although existing data are primarily retrospective in nature and further study is required, literature supports early VTE chemoprophylaxis initiation even for severely injured patients. Early initiation is most frequently defined as <48 hours from admission but varies from <24 hours to 72 hours and occasionally refers to time from initial trauma. Prior to chemical VTE prophylaxis initiation in patients at risk for bleeding, an observation period is necessary during which injuries must show themselves to be hemostatic, either clinically or radiographically. In the future, prospective examination of optimal timing of VTE prophylaxis is necessary. Further study of specific subsets of trauma patients will allow for development of effective VTE mitigation strategies based upon collective risks of VTE and hemorrhage progression.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 484-489 |
| Número de páginas | 6 |
| Publicación | Journal of Trauma and Acute Care Surgery |
| Volumen | 94 |
| N.º | 3 |
| DOI | |
| Estado | Published - mar 1 2023 |
Nota bibliográfica
Publisher Copyright:© Wolters Kluwer Health, Inc. All rights reserved.
Financiación
Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R13HL158206 (“Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma”). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Author ERH reports research funding from The Patient-Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality (AHRQ), the NIH/NHLBI, and the DOD/Army Medical Research Acquisition Activity. Otherwise, the study authors have no conflicts of interest or disclosures of funding to declare.
| Financiadores | Número del financiador |
|---|---|
| Army | |
| National Institutes of Health (NIH) | R13HL158206 |
| National Institutes of Health (NIH) | |
| U.S. Department of Defense | |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| Agency for Healthcare Research and Quality | |
| Patient-Centered Outcomes Research Institute |
ASJC Scopus subject areas
- Surgery
- Critical Care and Intensive Care Medicine
Huella
Profundice en los temas de investigación de 'Timing of venous thromboembolism prophylaxis initiation after injury: Findings from the consensus conference to implement optimal VTE prophylaxis in trauma'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver